RO-5508887
CAS No. 1310347-50-2
RO-5508887( RO 5508887 | RO5508887 | RG-7129 | RG7129 )
Catalog No. M11242 CAS No. 1310347-50-2
A potent, selective BACE inhibitor with IC50 of 30 nM for BACE1, equally potent against BACE2 (IC50=40 nM) .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 374 | Get Quote |
|
| 50MG | 1935 | Get Quote |
|
| 100MG | 2790 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRO-5508887
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective BACE inhibitor with IC50 of 30 nM for BACE1, equally potent against BACE2 (IC50=40 nM) .
-
DescriptionA potent, selective BACE inhibitor with IC50 of 30 nM for BACE1, equally potent against BACE2 (IC50=40 nM) but >1,000-fold selectivity over cathepsin D, cathepsin E, pepsin and renin; has IC50 of 18 nM in HEK293APP cells and in neuronal cultures derived from human neuronal stem cells; significantly enhances antiamyloid effect combined with gantenerumab.Alzheimer Disease Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsRO 5508887 | RO5508887 | RG-7129 | RG7129
-
PathwayMetabolic Enzyme/Protease
-
TargetBACE
-
RecptorBACE
-
Research AreaNeurological Disease
-
IndicationAlzheimer Disease
Chemical Information
-
CAS Number1310347-50-2
-
Formula Weight389.338
-
Molecular FormulaC18H14F3N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 85 mg/mL (218.32 mM)
-
SMILESCC1(C(COC(=N1)N)(F)F)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F
-
Chemical Name5-Cyano-pyridine-2-carboxylic acid [3-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-[1,3]oxazin-4-yl)-4-fluorophenyl]amide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jacobsen H, et al. J Neurosci. 2014 Aug 27;34(35):11621-30.
molnova catalog
related products
-
Elenbecestat (b)
Elenbecestat (E2609)?is a novel potent, oral BACE1 inhibitor for treatment of Alzheimer's disease.
-
LY2886721
LY2886721 is a highly potent, selective BACE1 aspartyl protease inhibitor with IC50 of 20.3 and 10.2 nM for BACE1 and BACE2.
-
Aloeresin D
Aloeresin D a natural chromone glycoside inhibits β-Secretase (BACE1) activity (IC50: 39 μM).
Cart
sales@molnova.com